I sat down with Chris Gibson, co-founder and CEO of Recursion, for part two of a series following up on a few pieces I wrote on pharma software and data including Real World Evidence and R&D tools. Chris and Recursion are at the forefront of using AI for drug discovery. We discussed how Recursion predicted drugs that would be effective for COVID, his take on different techbio business models, and what pharma R&D will look like in 25 years. Check it out on
I just finished reading The Billion Dollar Molecule by Barry Werth about Vertex Pharma and was struck listening to this episode how Recursion is building the 21st century version of the their pitch for "rational drug development".
Thanks for posting